原发性干燥综合征独立促进早发亚临床动脉粥样硬化
本研究连续纳入原发性干燥综合征(pSS)患者并按2:1匹配年龄性别对照,经倾向性评分匹配全部心血管危险因素后,pSS组颈动脉内膜中层厚度(cIMT)更大且斑块范围更广(OR=1.82;95%CI 1.14至2.95);伴器官受累的pSS患者cIMT及斑块发生均高于无器官受累者(OR=1.74;95%CI 1.02至3.01);oxLDL抗体在斑块患者中趋于更低(p=0.052)。
要点
- pSS患者亚临床动脉粥样硬化出现更早更重,匹配心血管危险因素后cIMT仍更大(p<0.001),斑块范围OR=1.82(95%CI 1.14至2.95)。
- 伴器官受累的pSS患者cIMT升高(p=0.025),斑块发生高于无器官受累者(OR=1.74;95%CI 1.02至3.01)。
- oxLDL抗体在斑块患者中趋于更低(p=0.052),与ESSDAI(p<0.001)及抗SSA/Ro抗体(p=0.026)呈正相关。
核心结论
- pSS患者亚临床动脉粥样硬化出现更早且更严重。
- pSS与对照的cIMT差异似乎主要由伴器官受累的患者驱动,提示该亚组风险尤其高。
- oxLDL抗体可能对pSS患者动脉粥样硬化进展具有保护作用。
- 应讨论心血管危险分层及预防性药物如HMG-CoA还原酶抑制剂,并需进一步纵向研究。
研究设计与样本
- 研究连续纳入风湿科门诊pSS患者,并招募年龄性别匹配对照(2:1比例)。
- 采用标准化问卷和多普勒超声评估斑块范围及颈动脉内膜中层厚度(cIMT)。
- 倾向性评分匹配纳入所有心血管危险因素及相应实验室标志物。
- 数据来自299名参与者(199例pSS/100例对照),年龄59.4岁(50.6-65.0),男性占19.1%。
主要发现
- 匹配后pSS队列cIMT大于对照(p<0.001),斑块范围OR=1.82(95%CI 1.14至2.95)。
- pSS亚组分析显示器官受累与cIMT升高相关(p=0.025),斑块发生高于无器官受累者(OR=1.74;95%CI 1.02至3.01)。
- oxLDL抗体在斑块患者中趋于更低(p=0.052)。
- oxLDL抗体较高与EULAR干燥综合征疾病活动指数(p<0.001)及抗SSA/Ro抗体(p=0.026)相关。
临床怎么用
- 作者认为应讨论心血管危险分层及预防性药物如HMG-CoA还原酶抑制剂。
- 作者指出需进一步纵向研究。
局限性
- 作者指出需进一步纵向研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Cardiovascular comorbidities are common in patients with autoimmune diseases. This study investigates the extent of subclinical atherosclerosis in patients with primary Sjögren's syndrome (pSS). Correlations with clinical factors such as organ involvement (OI) or disease activity were analysed and oxLDL antibodies (oxLDL ab) were measured as potential biomarkers of vascular damage. METHODS: Patients with pSS were consecutively included from the rheumatology outpatient clinic. Age- and sex-matched controls were recruited (2:1 ratio). Data collection was performed by a standardised questionnaire and Doppler ultrasound to evaluate the plaque extent and carotid intima-media thickness (cIMT). Propensity score matching included all cardiovascular risk (CVR) factors and corresponding laboratory markers. RESULTS: Data were available for 299 participants (199 pSS/100 controls), aged 59.4 years (50.6-65.0), 19.1% male. After matching, the pSS cohort had greater cIMT (p<0.001) and plaque extent (OR=1.82; 95% CI 1.14 to 2.95). Subgroup analyses of patients with pSS revealed that OI was associated with increased cIMT (p=0.025) and increased plaque occurrence compared with patients without OI (OR=1.74; 95% CI 1.02 to 3.01). OxLDL ab tended to be lower in patients with plaque (p=0.052). Correlations of higher Oxidized Low Density Lipoprotein (oxLDL) ab with EULAR Sjögren's Syndrome Disease Activity Index (p<0.001) and anti-Sjögren's-syndrome-related antigen A autoantibodies (SSA/Ro antibodies) (p=0.026) were observed. CONCLUSIONS: Subclinical atherosclerosis occurs earlier and more severely in patients with pSS. The difference in cIMT between pSS and controls seems mainly driven by patients with OI, suggesting that this subgroup is particularly at risk. OxLDL ab might protect against atherosclerotic progression in patients with pSS. CVR stratification and preventive medications such as Hydroxymethylglutaryl-CoA (HMG-CoA) reductase inhibitors should be discussed and further longitudinal studies are needed.
引用
- Zehrfeld N, Abelmann M, Benz S, et al. Primary Sjögren's syndrome independently promotes premature subclinical atherosclerosis. RMD Open. 2024. PMID: 38663882. doi:10.1136/rmdopen-2023-003559
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。